Funabashi Central Hospital
In research, Funabashi Central Hospital stands highest in Medicine (#17,444 of 17,978 worldwide) and Health Sciences (#20,074 of 20,462 worldwide), over all time.
- World rank, all time
- #42,092 of 42,892
- Rank in Japan
- #2,072 of 2,112
- Research works
- 174 ▼ 12% vs 2013–17
- Citations
- 1.8k 10.4 per fractional work
- Top-10% rate
- 6.7% record average 16.5%
- Open access
- 53% world 28%
What is Funabashi Central Hospital known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #17,444 of 17,978 | 5.7% | 143 | |
| Health SciencesDomain | #20,074 of 20,462 | 5.6% | 149 |
Each strip is that field’s whole ranked pool, with the notch where Funabashi Central Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.
Which keywords describe research at Funabashi Central Hospital?
By fractional works in all years, weighted toward what it does more of than the world: Survival Analysis, Diagnosis, Clinical Practice Guidelines, Treatment, Surgical Management, Chemotherapy, Gastric Cancer and Epidemiology.
- Cancer Treatment
- Imatinib Mesylate
- Neoadjuvant Therapy
- Lung Tumors
- Therapeutic Targets
- Peritoneal Metastases
- Clinical Trials
- Prognostic Markers
- Metastatic Gastric Cancer
- Neoadjuvant Chemotherapy
- Endoscopic Resection
- Adjuvant Therapy
- Molecular Characterization
- Immunotherapy
- Complications
- Prognostic Factors
- Gastric Cancer
- Chemotherapy
- Diagnosis
- Treatment
- Epidemiology
- Survival Analysis
- Clinical Practice Guidelines
- Surgical Management
- Inflammation
- Management
- Immunohistochemistry
- Genetic Mutations
- Breast Cancer
- Cytoreductive Surgery
- Molecular Profiling
- Lymph Node Dissection
- Colorectal Cancer
- Children
- Intraperitoneal Chemotherapy
- Hepatocellular Carcinoma
- Imaging
- Metastatic Carcinomas
- Laparoscopic Surgery
- Surgery
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology20▲ 2.9×52 topics
- Treatment15▲ 6.5×21 topics
- Survival Analysis14▲ 30×6 topics
- Diagnosis14▲ 8.0×16 topics
- Clinical Practice Guidelines14▲ 14×9 topics
- Chemotherapy12▲ 10×11 topics
- Surgical Management12▲ 16×11 topics
- Gastric Cancer12▲ 56×3 topics
- Inflammation11▲ 2.6×28 topics
- Prognostic Factors9▲ 12×11 topics
- Management8▲ 6.3×13 topics
- Complications8▲ 8.9×10 topics
- Immunohistochemistry8▲ 46×3 topics
- Immunotherapy7▲ 6.5×14 topics
- Genetic Mutations7▲ 8.0×12 topics
- Molecular Characterization7▲ 23×4 topics
- Breast Cancer7▲ 14×4 topics
- Adjuvant Therapy7▲ 34×2 topics
- Cytoreductive Surgery7▲ 59×2 topics
- Endoscopic Resection7▲ 40×2 topics
- Molecular Profiling6▲ 31×3 topics
- Neoadjuvant Chemotherapy6▲ 40×2 topics
- Lymph Node Dissection6▲ 59×1 topic
- Metastatic Gastric Cancer6▲ 59×1 topic
- Colorectal Cancer5▲ 33×3 topics
- Prognostic Markers5▲ 33×3 topics
- Children5▲ 12×4 topics
- Clinical Trials5▲ 4.8×9 topics
- Intraperitoneal Chemotherapy5▲ 166×1 topic
- Peritoneal Metastases5▲ 166×1 topic
- Hepatocellular Carcinoma5▲ 13×3 topics
- Therapeutic Targets5▲ 12×3 topics
- Imaging5▲ 7.6×5 topics
- Lung Tumors5▲ 124×1 topic
- Metastatic Carcinomas5▲ 124×1 topic
- Neoadjuvant Therapy4▲ 12×5 topics
- Laparoscopic Surgery4▲ 23×4 topics
- Imatinib Mesylate4▲ 44×2 topics
- Surgery4▲ 7.5×7 topics
- Cancer Treatment4▲ 9.4×4 topics
Which research topics does Funabashi Central Hospital publish most on?
By volume in 2022–2025: Colorectal Cancer Surgical Treatments, Plant Disease Resistance and Genetics, Cholangiocarcinoma and Gallbladder Cancer Studies and Cancer and Skin Lesions.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Colorectal Cancer Surgical Treatments Oncology 1 works
- 2 Plant Disease Resistance and Genetics Plant Science 0 works
- 3 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 0 works
- 4 Cancer and Skin Lesions Dermatology 0 works
- 5 Aortic aneurysm repair treatments Pulmonary and Respiratory Medicine 0 works
- 6 Congenital Heart Disease Studies Epidemiology 0 works
- 7 Child Abuse and Related Trauma Pediatrics, Perinatology and Child Health 0 works
- 8 Hernia repair and management Surgery 0 works
- 9 Intestinal Malrotation and Obstruction Disorders Surgery 0 works
- 10 Neonatal and fetal brain pathology Pediatrics, Perinatology and Child Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Funabashi Central Hospital's research output changed?
Output in 2018–2022 was 12% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Funabashi
- Chiba Hospital
- Funabashi Municipal Medical Center
- Funabashi Orthopaedic Hospital
- Funabashi Keimei High School
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.